Suppr超能文献

手术与胸腔内纤维蛋白溶解治疗复杂性胸腔感染:系统评价和荟萃分析。

Surgery versus intrapleural fibrinolysis for management of complicated pleural infections: a systematic review and meta-analysis.

机构信息

George Hospital, Kogarah, Sydney, Australia.

Department of Cardiothoracic Surgery, Central Clinical School, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.

出版信息

Respir Res. 2024 Aug 24;25(1):323. doi: 10.1186/s12931-024-02949-1.

Abstract

BACKGROUND

Complicated pleural infection comprises of complex effusions and empyema. When tube thoracostomy is ineffective, treatment options include surgical drainage, deloculation and decortication or intrapleural fibrinolysis. We performed a systematic review and meta-analysis to examine which technique is superior in treating complicated pleural infections.

METHODS

PubMed, MEDLINE and EMBASE databases were searched for studies published between January 2000 to July 2023 comparing surgery and intrapleural fibrinolysis for treatment of complicated pleural infection. The primary outcome was treatment success. Secondary outcomes included hospital length of stay, chest drain duration and in-hospital mortality.

RESULTS

Surgical management of complicated pleural infections was more likely to be successful than intrapleural fibrinolysis (RR 1.18; 95% CI 1.02, 1.38). Surgical intervention group benefited from statistically significant shorter hospital length of stay (MD: 3.85; 95% CI 1.09, 6.62) and chest drain duration (MD: 3.42; 95% CI 1.36, 5.48). There was no observed difference between in-hospital mortality (RR: 1.00; 95% CI 0.99, 1.02).

CONCLUSION

Surgical management of complicated pleural infections results in increased likelihood of treatment success, shorter chest drain duration and hospital length of stay in the adult population compared with intrapleural fibrinolysis. In-hospital mortality did not differ. Large cohort and randomized research need to be conducted to confirm these findings.

摘要

背景

复杂胸腔感染包括复杂性胸腔积液和脓胸。当胸腔引流管无效时,治疗选择包括手术引流、去粘连和剥脱术或胸腔内纤维蛋白溶解。我们进行了系统评价和荟萃分析,以检查哪种技术在治疗复杂胸腔感染方面更具优势。

方法

检索了 2000 年 1 月至 2023 年 7 月期间在 PubMed、MEDLINE 和 EMBASE 数据库上发表的比较手术和胸腔内纤维蛋白溶解治疗复杂胸腔感染的研究。主要结局是治疗成功率。次要结局包括住院时间、胸腔引流时间和院内死亡率。

结果

与胸腔内纤维蛋白溶解相比,手术治疗复杂胸腔感染更有可能成功(RR 1.18;95%CI 1.02,1.38)。手术干预组在住院时间(MD:3.85;95%CI 1.09,6.62)和胸腔引流时间(MD:3.42;95%CI 1.36,5.48)方面均有显著缩短。院内死亡率无明显差异(RR:1.00;95%CI 0.99,1.02)。

结论

与胸腔内纤维蛋白溶解相比,成人中手术治疗复杂胸腔感染可增加治疗成功率,缩短胸腔引流时间和住院时间,但院内死亡率无差异。需要进行大型队列和随机研究来证实这些发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验